Ian Hodgson's most recent trade in Corbus Pharmaceuticals Holdings Inc was a trade of 847 Common Stock, par value $0.0001 per share done at an average price of $7.4 . Disclosure was reported to the exchange on Feb. 17, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Corbus Pharma Holdings Inc | Ian Hodgson | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 7.38 per share. | 17 Feb 2026 | 847 | 51,080 (0%) | 0% | 7.4 | 6,253 | Common Stock, par value $0.0001 per share |
| Corbus Pharma Holdings Inc | Ian Hodgson | Chief Operating Officer | Sale of securities on an exchange or to another person at price $ 8.09 per share. | 03 Feb 2026 | 2,415 | 51,927 (0%) | 0% | 8.1 | 19,537 | Common Stock, par value $0.0001 per share |
| Corbus Pharma Holdings Inc | Ian Hodgson | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2026 | 85,095 | 85,095 | - | - | Stock options (right to buy) | |
| Corbus Pharma Holdings Inc | Ian Hodgson | Chief Operating Officer | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 14 Jan 2026 | 28,365 | 54,342 (0%) | 0% | 0 | Common Stock, par value $0.0001 per share |